論文

査読有り 筆頭著者 本文へのリンクあり 国際誌
2019年11月

Immunofluorescence analysis of DNA damage response protein p53-binding protein 1 in a case of uterine dedifferentiated leiomyosarcoma arising from leiomyoma

Pathology - Research and Practice
ダウンロード
回数 : 17
  • Katsuya Matsuda
  • Yuko Akazawa
  • Yuka Yamaguchi
  • Zhanna Mussazhanova
  • Hirokazu Kurohama
  • Nozomi Ueki
  • Michiharu Kohno
  • Ai Fukushima
  • Itsuki Kajimura
  • Hiroko Hiraki
  • Takahiro Matsuwaki
  • Sayaka Kawashita
  • Akira Kinoshita
  • Masahiro Nakashima
  • 全て表示

215
11
開始ページ
152640
終了ページ
152640
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1016/j.prp.2019.152640
出版者・発行元
Elsevier BV

AIMS: Genomic instability has been indicated during the dedifferentiation process from leiomyoma (LM) to leiomyosarcoma (LMS). Previously, we have described that nuclear expression pattern of DNA damage response protein p53-binding protein 1 (53BP1), detected by immunofluorescence, reflects the magnitude of genomic instability during malignancy. Here, we present a case of LMS arising from LM with molecular analysis of 53BP1, which showed transitional magnitude of DNA damage response within a tumor. METHODS AND RESULTS: A fifty-year-old female with abdominal mass underwent hysterectomy. Histologically, the tumor consisted of LMS with highly atypical multinucleated giant cells as well as an LM component with transitional atypical spindle cells in the border area. LMS showed diffuse nuclear staining of 53BP1 expression, which has been previously described as high DNA damage response pattern. In contrast, the LM component lacked 53BP1 immunoreactivity and focal expression was observed in transitional lesion. Furthermore, double-labelled immunofluorescence revealed co-localization of 53BP1 with p53 and Ki-67 in the LMS component, which indicated abnormal DNA damage response in proliferative state. CONCLUSIONS: This study revealed that diffuse-type 53BP1 expression may be beneficial to estimate genomic instability during dedifferentiation from LM to DLMS.

リンク情報
DOI
https://doi.org/10.1016/j.prp.2019.152640
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31570279
ID情報
  • DOI : 10.1016/j.prp.2019.152640
  • ISSN : 0344-0338
  • PubMed ID : 31570279

エクスポート
BibTeX RIS